Results
Mankind Pharma Q2 Revenue Up 17% with 27.1% EBITDA Margin
Mankind Pharma reported Q2 FY27 revenue of ₹4,338 crore, up 17% YoY, with EBITDA margin expanding 210 bps to 27.1%.
Domestic business ex-consumer healthcare grew 15.9% YoY, outperforming IPM growth wi
